| NDC Code | 71773-100-12 |
|---|
| Package Description | 12 CARTON in 1 PACKAGE (71773-100-12) / 1 VIAL, GLASS in 1 CARTON (71773-100-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
|---|
| Product NDC | 71773-100 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Xerava |
|---|
| Non-Proprietary Name | Eravacycline |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20180910 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA211109 |
|---|
| Manufacturer | Tetraphase Pharmaceuticals, Inc. |
|---|
| Substance Name | ERAVACYCLINE DIHYDROCHLORIDE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Tetracycline-class Antibacterial [EPC], Tetracyclines [CS] |
|---|